In this post, I link to the COVID-19 Guidelines from The NIH.
All that follows are links from the above resource.
About the Guidelines
What’s New in the Guidelines
Last Updated: January 10, 2023
The Coronavirus Disease 2019 (COVID-19) Treatment Guidelines is published in an electronic format that can be updated in step with the rapid pace and growing volume of information regarding the treatment of COVID-19.
The COVID-19 Treatment Guidelines Panel (the Panel) is committed to updating this document to ensure that health care providers, patients, and policy experts have the most recent information regarding the optimal management of COVID-19 (see the Panel Roster for a list of Panel members).
Guidelines Development
Last Updated: December 1, 2022
The COVID-19 Treatment Guidelines were developed to provide clinicians with guidance on caring for patients with COVID-19. Because clinical information about the optimal management of COVID-19 is evolving quickly, these Guidelines are updated frequently to reflect newly published data and other authoritative information.
Table of Contents
Last Updated: January 10, 2023
Below is an overview of the sections found in the Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.
Overview
Overview of COVID-19
Last Updated: December 1, 2022
Testing for SARS-CoV-2 Infection
Last Updated: August 8, 2022
Prevention of SARS-CoV-2 Infection
This page is currently under revision. Read this statement from the Panel for the most recent information on the use of tixagevimab plus cilgavimab (Evusheld) as PrEP of COVID-19.
Last Updated: December 1, 2022
